七月 2026
- Home
- Instrument Business Outlook
七月 2026的Instrument Business Outlook市场份额分析
Tariff announcements and changes in the academic and government funding landscape in the US are the latest challenges facing the laboratory tools industry. But, according to Strategic Directions International’s (SDi’s) 2025 “Global Assessment Report,” despite these challenges and others, the compound annual growth rate (CAGR) for laboratory instruments will increase in coming years. Five-Year Market […]
Instrument Business Outlook(包含公司地区分支机构)
查看更多网站流量和参与度信息- instrumentbusinessoutlook.com
Instrument Business Outlook收入截至 七月 2026为 2M - 5M
Instrument Business Outlook主要域名产生的收入
3 年中Instrument Business Outlook主要域名的收入
Instrument Business Outlook主要域名的收入
Instrument Business Outlook热门域名的总访问量
了解Instrument Business Outlook市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Instrument Business Outlook热门域名的平均访问时长
分析Instrument Business Outlook参与度指标。
过去 3 个月的平均访问时长
子公司明细
Instrument Business Outlook热门域名的平均页面浏览量
了解Instrument Business Outlook如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Instrument Business Outlook 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Instrument Business Outlook launches alphaCART, a portable research-grade confocal Raman system.Oxford Instruments WITec has unveiled alphaCART, a portable research-grade confocal Raman system, enabling researchers to conduct on-site chemical characterisation with the same speed, sensitivity, and resolution as WITec's stationary instruments.
九月 5, 2023阅读更多
新闻Instrument Business Outlook partners with Twist Bioscience Corporation.“Instrument Business Outlook is delighted to partner with Twist Bioscience, an exciting technology platform company who will enhance its antibody discovery capabilities with their highly diverse phage display libraries,” said Hamish Ryder, CEO of Therapeutic Innovation at Cancer Research Horizons.
七月 17, 2023阅读更多
新闻Instrument Business Outlook launched AAV-Tek AEX Buffer Screening Kit for AAV2 on Jun 11th '23.“After Instrument Business Outlook introduced its first proprietary gene therapy product a few months ago – the AAV-Tek AEX Buffer Screening Kit for AAV2 – customers encouraged Instrument Business Outlook to create additional solutions to better support AAV gene therapy developers,” said Stephen Gunstream, Teknova’s President and Chief Executive Officer.
七月 10, 2023阅读更多
查看 Instrument Business Outlook 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
